Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Dose–Response for Laryngeal Mask Airway Insertion With or Without Lidocaine in Shoulder Arthroscopy
ChiCTR2500108472Phase 4Not yet recruiting
- Sponsor
- Ningbo No. 6 Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Shoulder disorder and None (2 arms), sponsored by Ningbo No. 6 Hospital. Primary endpoint: Laryngeal mask airway insertion response. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Shoulder disorder
Beyond the preview
Go deeper on ChiCTR2500108472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108472.